Dr. Duerst is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2300 N Childrens Plz
Chicago, IL 60614Phone+1 773-975-8512Fax+1 773-880-3223
Summary
- Reggie Duerst, MD is a retired (2021) Pediatric Hematology & Oncology specialist previously based at Lurie Children’s Hospital in Chicago, IL. He received his medical degree from the University of Wisconsin School of Medicine & Public Health in 1979 and finished his residency in Pediatrics at the University of Rochester, where he also pursued a fellowship in Pediatric Hematology and Oncology from 1982-1985.
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 1984 - 1985
- University of RochesterResidency, Pediatrics, 1979 - 1984
- University of Wisconsin School of Medicine & Public HealthClass of 1979
Certifications & Licensure
- IL State Medical License 2000 - 2023
- American Board of Pediatrics Pediatrics
Clinical Trials
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) Start of enrollment: 2000 Mar 10
- Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsReduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-ri...Jenna Rossoff, David A. Jacobsohn, Soyang Kwon, Morris Kletzel, Reggie E. Duerst
Pediatric Blood & Cancer. 2021-05-22 - 25 citationsOutcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal F...David A. Jacobsohn, Michael R. Loken, Mingwei Fei, Alexia Adams, Lisa Eidenschink Brodersen
Biology of Blood and Marrow Transplantation. 2018-10-01 - 3 citationsFecal calprotectin and serum albumin as markers of gastrointestinal graft versus host diseaseLarisa Broglie, Alfred Rademaker, John P. Galvin, Ayita Ray, William T. Tse
Hematology/oncology and Stem Cell Therapy. 2018-09-01
Press Mentions
- Chicago Hospitals in Vanguard of Gene Therapy for Pediatric CancerAugust 30th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: